Results 21 to 30 of about 1,218,074 (349)

Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Atrial tissue fibrosis is linked to inflammatory cells, yet is incompletely understood. A growing body of literature associates peripheral blood levels of the antifibrotic hormone BNP (B‐type natriuretic peptide) with atrial fibrillation (AF).
Chris J. Watson, Nadezhda Glezeva, Stephen Horgan, Joe Gallagher, Dermot Phelan, Ken McDonald, Michael Tolan, John Baugh, Patrick Collier, Mark Ledwidge   +9 more
doaj   +1 more source

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension

Frontiers in Pharmacology, 2022
Background: Although major advances have been made in the pathogenesis and management of pulmonary arterial hypertension (PAH), the endothelin system is still considered to play a vital role in the pathology of PAH due to its vasoconstrictive action ...
Zeyu Zhang, Zeyu Zhang, Zeyu Zhang, Chunlei Liu, Chunlei Liu, Yongyi Bai, Xin Li, Xin Li, Xiaojian Gao, Xiaojian Gao, Xiaojian Gao, Chen Li, Chen Li, Ge Guo, Ge Guo, Si Chen, Mingzhuang Sun, Kang Liu, Yang Li, Kunlun He, Kunlun He   +20 more
doaj   +1 more source

Chronic heart failure

Australian Journal of Physiotherapy, 2008
Chronic heart failure (CHF) is a major healthcare problem. CHF is both physically and emotionally disabling and has a major impact on quality of life. Moreover, CHF has a long-term prognosis comparable to or worse than most common malignancies. 1 It is a frequent reason for unplanned hospital admissions, and has a major impact on healthcare resources ...
Mark T. Kearney, Helen Williams
openaire   +4 more sources

Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital

The Journal of Clinical Hypertension, 2021
It is widely recognized that hypertension is one of the major risk factor for disease severity and mortality in patients with coronavirus disease 2019 (COVID‐19). However, type 2 diabetes mellitus (T2DM) and hypertension are frequent comorbid conditions,
Yuhui Sun, Xizhou Guan, Lijing Jia, Ning Xing, Liuquan Cheng, Bo Liu, Sibing Zhang, Kunlun He   +7 more
doaj   +1 more source

F2RL3 Methylation in the Peripheral Blood as a Potential Marker for the Detection of Coronary Heart Disease: A Case-Control Study

Frontiers in Genetics, 2022
Background and Aims: Previous work has shown the association between blood-based methylation of coagulation factor II receptor-like 3 gene (F2RL3) and cardiovascular mortality in Caucasians.
Xiaojing Zhao, Xiaojing Zhao, Liya Zhu, Qiming Yin, Zhenguo Xu, Zhenguo Xu, Qian Jia, Qian Jia, Rongxi Yang, Kunlun He, Kunlun He   +10 more
doaj   +1 more source

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2012
Authors/Task Force Members: John J.V. McMurray (Chairperson) (UK)*, Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Angelo Auricchio (Switzerland), Michael Bohm (Germany), Kenneth Dickstein (Norway), Volkmar Falk (Switzerland), Gerasimos ...
J. McMurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M. Gómez-Sánchez, T. Jaarsma, L. Køber, G. Lip, A. Maggioni, A. Parkhomenko, B. Pieske, B. Popescu, P. Rønnevik, F. Rutten, J. Schwitter, P. Seferovic, J. Stȩpińska, P. Trindade, A. Voors, F. Zannad, A. Zeiher, J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, Ž. Reiner, U. Sechtem, P. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, L. A. Bonet, P. Avraamides, Hisham A. Ben Lamin, M. Brignole, A. Coca, Peter Cowburn, H. Dargie, P. Elliott, F. Flachskampf, Guido Francesco Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J. Nanas, O. Nielsen, S. Ørn, J. Parissis, P. Ponikowski   +65 more
semanticscholar   +1 more source

A Multi-Task Neural Network Architecture for Renal Dysfunction Prediction in Heart Failure Patients With Electronic Health Records

IEEE Access, 2019
Renal dysfunction, which is associated with bad clinical outcomes, is one of the most common complications of heart failure (HF). Timely prediction of renal dysfunction can help medical staffs intervene early to avoid catastrophic consequences.
Binhua Wang, Yongyi Bai, Zhenjie Yao, Jiangong Li, Wei Dong, Yanhui Tu, Wanguo Xue, Yaping Tian, Yifei Wang, Kunlun He   +9 more
doaj   +1 more source

Construction of a Non-Mutually Exclusive Decision Tree for Medication Recommendation of Chronic Heart Failure

Frontiers in Pharmacology, 2022
Objective: Although guidelines have recommended standardized drug treatment for heart failure (HF), there are still many challenges in making the correct clinical decisions due to the complicated clinical situations of HF patients.
Yongyi Bai, Yongyi Bai, Haishen Yao, Xuehan Jiang, Suyan Bian, Suyan Bian, Jinghui Zhou, Xingzhi Sun, Gang Hu, Lan Sun, Guotong Xie, Kunlun He, Kunlun He   +12 more
doaj   +1 more source

Using artificial intelligence in the development of diagnostic models of coronary artery disease with imaging markers: A scoping review

Frontiers in Cardiovascular Medicine, 2022
BackgroundCoronary artery disease (CAD) is a progressive disease of the blood vessels supplying the heart, which leads to coronary artery stenosis or obstruction and is life-threatening.
Xiao Wang, Xiao Wang, Xiao Wang, Junfeng Wang, Wenjun Wang, Wenjun Wang, Wenjun Wang, Mingxiang Zhu, Mingxiang Zhu, Mingxiang Zhu, Hua Guo, Junyu Ding, Jin Sun, Jin Sun, Jin Sun, Di Zhu, Di Zhu, Di Zhu, Yongjie Duan, Yongjie Duan, Yongjie Duan, Xu Chen, Xu Chen, Xu Chen, Peifang Zhang, Zhenzhou Wu, Kunlun He, Kunlun He, Kunlun He   +28 more
doaj   +1 more source

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

New England Journal of Medicine, 2004
BACKGROUND We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with ...
M. Bristow, L. Saxon, J. Boehmer, S. Krueger, D. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B. G. White, Dale W Devries, A. Feldman   +11 more
semanticscholar   +1 more source